Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_assertion type Assertion NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_head.
- NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_assertion description "[We further showed that inferior OS and DSS were most pronounced in patients whose lymphomas contained both TNFRSF14 mutations and 1p36 deletions after adjustment for the International Prognostic Index [hazard ratios of 3.65 (95% confidence interval, 1.35-9.878, P=0.011) and 3.19 (95% confidence interval, 1.06-9.57, P=0.039), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_provenance.
- NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_assertion evidence source_evidence_literature NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_provenance.
- NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_assertion SIO_000772 20884631 NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_provenance.
- NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_assertion wasDerivedFrom befree-20150227 NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_provenance.
- NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_assertion wasGeneratedBy ECO_0000203 NP804742.RAP-uhMo3uHkIbCcelcjdK4cT9NHYyqqm3n96dXngOUPg130_provenance.